Stay updated on Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record and navigation with an access-denied screen. This indicates a restriction or system issue that prevents viewing the trial details.SummaryDifference18%

- Check55 days agoChange DetectedRevision: v3.6.6 appears on the page, replacing the previous Revision: v3.6.5 in the footer, indicating a recent update to the page metadata. This update does not modify study content or visible data, but refreshes the document version tracked by the site.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page now lists sponsor and collaborators (e.g., Washington University School of Medicine and NovoCure Ltd.) and adds links to essential documents (Study Protocol and Statistical Analysis Plan) plus related terminology, expanding the contextual resources for this trial.SummaryDifference50%

- Check76 days agoChange DetectedThe page's revision tag was updated to v3.6.5, replacing v3.6.4. This indicates a minor maintenance update to the page rather than a change to study content or eligibility details.SummaryDifference0.1%

Stay in the know with updates to Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.